Alexander Rosenstein - Cardiovascular Systems General Counsel and Corporate Secretary
| CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Executive
Mr. Alexander Rosenstein is General Counsel and Corporationrationrate Secretary of the Company. Mr. Rosenstein joined us in September 2014 as Corporationrationrate Legal and Compliance Counsel, became Corporationrationrate Secretary in November 2014, and was promoted to General Counsel in March 2015. From October 2005 to September 2014, Mr. Rosenstein was an attorney at Fredrikson Byron, P.A., which provides legal services to us from time to time, and from September 1998 to September 2005, he was an attorney practicing in New York City. since 2015.
| Age | 51 |
| Tenure | 9 years |
| Phone | 651 259 1600 |
| Web | https://www.csi360.com |
Cardiovascular Systems Management Efficiency
The company has return on total asset (ROA) of (0.0756) % which means that it has lost $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1518) %, meaning that it created substantial loss on money invested by shareholders. Cardiovascular Systems' management efficiency ratios could be used to measure how well Cardiovascular Systems manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 22.15 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cardiovascular Systems has a current ratio of 5.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cardiovascular Systems until it has trouble settling it off, either with new capital or with free cash flow. So, Cardiovascular Systems' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cardiovascular Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cardiovascular to invest in growth at high rates of return. When we think about Cardiovascular Systems' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Chris Calcaterra | Glaukos Corp | 64 | |
| Brandon Kraatz | Paragon 28 | N/A | |
| Mark MS | Outset MedicalInc | 67 | |
| Andrew Hill | Paragon 28 | 40 | |
| Frank Vizesi | Orthofix Medical | N/A | |
| Irina Ridley | Neuropace | 38 | |
| Tara Dunn | Inari MedicalInc | N/A | |
| Tram Bui | Orthopediatrics Corp | N/A | |
| Roberto Donadello | Orthofix Medical | N/A | |
| David Sandoval | MaxCyte | N/A | |
| Jeff Bertolini | Si Bone | N/A | |
| John Shumaker | Paragon 28 | N/A | |
| Trui Hebbelinck | LivaNova PLC | 52 | |
| John Ferrell | CONMED | 56 | |
| Craig Palmer | CVRx Inc | 47 | |
| Nathan Minnich | Treace Medical Concepts | N/A | |
| Paul Koehn | Inari MedicalInc | 61 | |
| Michael CFA | Rapid Micro Biosystems | N/A | |
| Robert JD | Paragon 28 | 56 | |
| Justin Ward | Bruker | N/A | |
| Christofer Christoforou | Nevro Corp | 54 | |
Management Performance
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 |
Cardiovascular Systems Leadership Team
Elected by the shareholders, the Cardiovascular Systems' board of directors comprises two types of representatives: Cardiovascular Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardiovascular. The board's role is to monitor Cardiovascular Systems' management team and ensure that shareholders' interests are well served. Cardiovascular Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardiovascular Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edward Brown, Independent Director | ||
| Stephen Rempe, Chief Officer | ||
| Jack Nielsen, Vice President Investor Relations & Corporate Communications | ||
| Peter Hirshman, VP Operations | ||
| Scott Ward, Chairman of the Board, Interim CEO and Presidentident | ||
| BSc MS, Pres Chairman | ||
| Alexander Rosenstein, General Counsel and Corporate Secretary | ||
| Jeffrey MD, Chief Officer | ||
| Laurence Betterley, CFO | ||
| Laura Gillund, Chief Talent Officer | ||
| John Nielsen, VP Communications | ||
| Scott Bartos, Independent Director | ||
| Sandra Sedo, Chief Compliance Officer | ||
| Rhonda Robb, COO | ||
| Jeffrey Points, Chief Officer | ||
| Leslie Trigg, Independent Director | ||
| William Cohn, Director | ||
| Brent Blackey, Independent Director | ||
| Philip Freed, VP Marketing | ||
| Augustine Lawlor, Independent Director | ||
| Paul Koehn, Sr. VP of Quality and Operations | ||
| Robert Thatcher, Chief Healthcare Policy Officer | ||
| Erik Paulsen, Independent Director | ||
| Kevin Kenny, COO | ||
| Martha Aronson, Independent Director |
Cardiovascular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardiovascular Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Shares Owned By Insiders | 3.22 % | |||
| Shares Owned By Institutions | 89.64 % | |||
| Number Of Shares Shorted | 1.74 M | |||
| Price To Earning | 724.24 X |
Pair Trading with Cardiovascular Systems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardiovascular Systems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiovascular Systems will appreciate offsetting losses from the drop in the long position's value.Moving together with Cardiovascular Stock
| 0.61 | CVI | CVR Energy Earnings Call This Week | PairCorr |
Moving against Cardiovascular Stock
| 0.75 | CSCO | Cisco Systems Fiscal Quarter End 30th of April 2024 | PairCorr |
| 0.51 | BA | Boeing Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Cardiovascular Systems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardiovascular Systems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardiovascular Systems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardiovascular Systems to buy it.
The correlation of Cardiovascular Systems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardiovascular Systems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardiovascular Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardiovascular Systems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |